News - Page 8

Five research environments from MED reached this year's FRIPRO award. One research environment from IMB and four from Klinmed received support.

Jeanette H. Magnus, Director of the Centre for Global Health at UiO contributed to discussions for a long-term plan for higher education and research at Universitets- og høgskolerådet (UHR) by presenting different paradigms and perspectives.

Molecular discoveries have the potential to lead to advancements in the understanding and treatment of disease. Over 90 scientists visited Oslo to discuss the latest dynamic kinetochore research

Dr Tatiana Belova (NCMM), Dr Salim Ghannoum (Oslo University Hospital) and Saikat Das Sajib (University of Tromsø) have been awarded the funding by the national network for breast cancer research

By using drugs currently used to treat other diseases, scientists hope they will help children with leukemia suffer fewer long-term aftereffects from their treatment.

In her new project, FINALphagy, Knævelsrud will study how autophagy is turned off in the body. One of the aims of her research is that it should be applicable in the development of new forms of cancer treatment.

Are you a student at bachelor's or master's program at the Faculty of Medicine, and interested to work with us?

Evandro Fei Fang will lead UiO's contribution to an extensive research project and network, financed through Horizon Europe. The goal is to develop a new medicine using artificial intelligence.

Many patients stop taking medication for high cholesterol because they are afraid it may have negative side effects. But the observed association between risk of dementia and high cholesterol, may be caused by your lifestyle.

The gene helps to repair brain damage caused by a lack of oxygen during birth, Norwegian researchers found.

We are thrilled to share the news that two of SHE's projects have been awarded Circle U. Interdisciplinary Thematic Research Network grant.

Anita Kavlie, national coordinator for EATRIS Norway, pitched the benefits of the EATRIS research infrastructure to a full house at innovation hangouts – a new meeting place for academia and industry organised by the Life Science Growth House

The origin of life on Earth is one of humankind’s greatest open questions. Researchers at NCMM wanted to investigate how the transition from non-living to living matter on the early-Earth took place by studying how molecules like DNA and RNA are exchanged between primitive cells

On the 13th & 14th of June NCMM held its first scientific retreat in three years. The retreat comprised of two days of excellent talks from the research environment and Associate Investigator network representing NCMM’s wide expertise in molecular medicine

Where are they now? Meet NCMM alumna Rønnaug Steen Kolve and learn about her career path from studies in molecular medicine to managing first a core facility at an international research center and then research funding actions at the Norwegian Cancer Society.

Dr Liye He is a Postdoctoral Researcher with a background in computational science and precision medicine in the group of Professor Tero Aittokallio at FIMM. He recently spent time with the Mathelier group at NCMM

Elham Shojaeinia is a PhD student in the Esguerra group at NCMM. She recently visited DANDRITE at Aarhus University, Denmark to learn in depth about the principles of neural organization

NCMM group leader, Dr Marieke Kuijjer and Dr Xavier Tekpli (Oslo University Hospital) have been awarded the funding by the foundation for the promotion of cancer research (UNIFOR-FRIMED)

Those who have passed the building site for the new life science building in Gaustadbekkdalen have probably noticed that there is full activity on the construction site at the moment. Seven high cranes tower into the air and construction machinery is in full operation. Some employees from the University of Oslo have visited the construction site.

Nathalie Frosthammer is studying at the Department for Biosciences, this summer she is one of 50 students participating in a research project with a scholarship from UiO:Life Science.

Inven2 presented "Innovator of the Year"-prize for the first time. Ole Jørgen Kaasbøll, head of research and one of the founders of the company Tribune Therapeutics, was awarded the prize at Innovation Day 2022.

Stenmark receives the award for his groundbreaking research on processes in cell membranes and how misregulation of such processes affects the development of cancer.

The environmental pollutants we consume are probably the reason why some people develop type 1 diabetes. Even low concentrations of such pollutants can result in cells producing less insulin, reveals a new study from the University of Oslo (UiO).

Inven2's Idépris 2022 goes to a virtual tool for developing antibodies. The idea was developed by Victor Greiff, head of the convergence environment ImmunoLingo, together with colleagues from the University of Oslo and Oslo University Hospital. 

Abnormal epigenetic changes are observed in the development of multiple types of cancer. Researchers at NCMM wanted to explore the molecular mechanisms driving these processes